BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36243397)

  • 1. Twenty-first century epidemiology of dyslipidemia in Greece: EMENO national epidemiological study.
    Stergiou GS; Ntineri A; Menti A; Kalpourtzi N; Vlachopoulos C; Liberopoulos EN; Rallidis L; Richter D; Gavana M; Vantarakis A; Chlouverakis G; Hajichristodoulou C; Trypsianis G; Voulgari PV; Alamanos Y; Karakosta A; Touloumi G
    Hellenic J Cardiol; 2023; 69():1-8. PubMed ID: 36243397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between serum cholinesterase and incident hyper-LDL cholesterolemia, hypertriglyceridemia and hypo-HDL cholesterolemia as well as changes in lipid levels in a health screening population.
    Oda E
    Atherosclerosis; 2015 Jul; 241(1):1-5. PubMed ID: 25935113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
    Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiological characteristics of dyslipidemia in remote rural areas of Xinjiang, 2009-2010].
    Wang YL; Yan YZ; He J; Ma JL; Zhang M; ; Zhang JY; Liu JM; Li SG; Niu Q; Rui DS; Ma RL; Guo H; Ding YS; Guo SX
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Nov; 50(11):996-1000. PubMed ID: 27916084
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevalence of dyslipidemia among residents aged 18-69 years in Shandong province of China, 2011].
    Zhang J; Tang J; Guo X; Dong J; Ren J; Chen X; Gao C; Xu A
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Mar; 50(3):230-4. PubMed ID: 26957240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.
    Erem C; Hacihasanoglu A; Deger O; Kocak M; Topbas M
    Endocrine; 2008; 34(1-3):36-51. PubMed ID: 19003544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of dyslipidemia and its associated factors among university academic staff and students in Bangladesh.
    Ali N; Kathak RR; Fariha KA; Taher A; Islam F
    BMC Cardiovasc Disord; 2023 Jul; 23(1):366. PubMed ID: 37479968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Patterns and the Risk of Dyslipidemia in Korean Adults: A Prospective Cohort Study Based on the Health Examinees (HEXA) Study.
    Kim SA; Shin S
    J Acad Nutr Diet; 2021 Jul; 121(7):1242-1257.e2. PubMed ID: 33158796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia Fact Sheet in South Korea, 2022.
    Jin ES; Shim JS; Kim SE; Bae JH; Kang S; Won JC; Shin MJ; Jin HY; Moon J; Lee H; Kim HC; Jeong IK
    Diabetes Metab J; 2023 Sep; 47(5):632-642. PubMed ID: 37528532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of dyslipidemia in Tunisia, HSHS 3 study (Hammam Sousse Sahloul Heart Study).
    Ben Hdia Z; Ben Abdelaziz A; Melki S; Ben Hassine D; Ben Rejeb N; Omezzine A; Bouslama A; Ben Abdelaziz A
    Tunis Med; 2022 avril; 100(4):323-334. PubMed ID: 36155904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and factors associated with dyslipidemia in Bangladeshi adults.
    Ali N; Samadder M; Kathak RR; Islam F
    PLoS One; 2023; 18(1):e0280672. PubMed ID: 36662845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study.
    Selim S; Alam MS; Talukder SK; Kabir ML; Gaffar AJ; Kabir MA; Zarin N; Rahman S; Nabi MMU; Mustari M; Hossain MF; Raunak AIB; Hoque MA; Islam MR; Akter F; Hannan MA; Saifuddin M; Asaduzzaman M; Rahman MM; Ahammed A; Rafi MA; Hasan MJ; Kamrul-Hasan ABM
    BMC Endocr Disord; 2023 Dec; 23(1):268. PubMed ID: 38053073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of plasma lipid abnormalities and associated risk factors among Iranian adults based on the findings from STEPs survey 2021.
    Khanali J; Ghasemi E; Rashidi MM; Ahmadi N; Ghamari SH; Azangou-Khyavy M; Malekpour MR; Abbasi-Kangevari M; Hashemi SM; Naderian M; Rezaei N; Dilmaghani-Marand A; Farzi Y; Kazemi A; Yoosefi M; Hajebi A; Rezaei S; Azadnajafabad S; Fattahi N; Nasserinejad M; Abdolhamidi E; Haghshenas R; Rezaei N; Djalalinia S; Larijani B; Farzadfar F
    Sci Rep; 2023 Sep; 13(1):15499. PubMed ID: 37726324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Blood Lipids on 10-Year Cardiovascular Risk in Individuals Without Dyslipidemia and With Low Risk Factor Burden.
    Zhou Z; Ong KL; Whelton SP; Allison MA; Curtis AJ; Blaha MJ; Breslin M; Tonkin A; Magnussen CG; Budoff M; Nelson MR
    Mayo Clin Proc; 2022 Oct; 97(10):1883-1893. PubMed ID: 35760597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The gender features of disorders of composition of lipids of blood serum in patients with chronic pathology of kidneys.].
    Murkamilov IT; Aytabaiev KA; Fomin VV; Murkamilova ZA; Rayimjanov ZR; Redjapova NA; Yusupov FA; Aydarov ZA
    Klin Lab Diagn; 2018; 63(3):152-158. PubMed ID: 30673194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002-2012).
    Georgoulis M; Chrysohoou C; Georgousopoulou E; Damigou E; Skoumas I; Pitsavos C; Panagiotakos D
    Lipids Health Dis; 2022 Dec; 21(1):141. PubMed ID: 36529737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cholesterol concentration and prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in the Korea National Health and Nutrition Examination Surveys 2008-2010: Beyond the Tip of the Iceberg.
    Lee YH; Lee SG; Lee MH; Kim JH; Lee BW; Kang ES; Lee HC; Cha BS
    J Am Heart Assoc; 2014 Feb; 3(1):e000650. PubMed ID: 24572249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
    Tóth PP; Potter D; Ming EE
    J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.